24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
Hospitals & Clinics
specialties & services
Dr. Vamsi Kota is a medical oncologist from Atlanta, Georgia and he works at several hospitals in the area, such as Emory University Hospital and Southern Regional Medical Center. He got his diploma from Armed Forces Medical College Pune and did his residency program in Internal Medicine and a fellowship program in Hematology/Oncology at Medical College of Georgia. The doctor is certified in Hematology, Internal Medicine, Medical Oncology and has an experience of more than 20 years.
AetnaBlue Cross of CaliforniaBlue Shield of CaliforniaCignaFirst Health PPOHumanaMultiPlan
Armed Forces Medical College Pune
Medical School
Medical College of Georgia
Residency
Medical College of Georgia
Fellowship
American Board of Internal Medicine - Oncology
Emory University Hospital
Languages: English/Spanish
(404) 712–2000
1364 Clifton Road NE
Atlanta, Georgia 30322-1102 
Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?
Kong, J. H.,Winton, E. F.,Heffner, L. T.,Chen, Z.,Langston, A. A.,Hill, B.,Arellano, M.,El-Rassi, F.,Kim, A.,Jillella, A.,Kota, V. K.,Bodó, I.,Khoury, H. J.; Cancer. 2017 Feb 28.
See more >>
Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients.
Hartranft ME, Clemmons AB, DeRemer DL, Kota V; J Oncol Pharm Pract. 2017-01-01.
See more >>
Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
DeFilipp Z, Langston AA, Chen Z, Zhang C, Arellano ML, El Rassi F, Flowers CR, Kota VK, Al-Kadhimi Z, Veldman R, Jillella AP, Lonial S, Waller EK, Khoury HJ; Clin Lymphoma Myeloma Leuk. 2016-08-01.
See more >>